(WASHINGTON, D.C.) – Consumer Healthcare Products Association (CHPA) President and CEO Scott Melville today released the below statement following the U.S. Senate voting to confirm Robert F. Kennedy Jr. to lead the Department of Health and Human Services (HHS) by a recorded vote of 52-48:
“CHPA and its member companies look forward to working with Secretary Kennedy to advance policies that will enhance American consumers’ access to safe, effective, and affordable self-care options. With a growing demand for OTC medicines, dietary supplements, and OTC medical devices, it is imperative that our nation’s healthcare leaders expand access, streamline regulatory pathways, and reinforce public confidence through transparent, data-driven decisions. This can be achieved through the reauthorization of the Over-the-Counter Monograph Drug User Fee Program (OMUFA), Rx-to-OTC switch improvements, and the modernization of the more than 30-year-old Dietary Supplement Health and Education Act (DSHEA).
“CHPA stands ready to collaborate with the Administration, Congress, and other stakeholders on advancing these and other critical policies that prioritize the essential role consumer healthcare products play in benefitting our nation’s public health.”
